The Valley Desk

Clinical trial reportThe Journal of clinical endocrinology and metabolismPublished

Safety and Efficacy of Moderate-dose Denosumab in Fibrous Dysplasia: Observational Results From a Phase 2 Clinical Trial

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
The Journal of clinical endocrinology and metabolism
Published
Subject terms
Humans; Fibrous Dysplasia of Bone; Treatment Outcome; Bone Remodeling; Dose-Response Relationship, Drug; Adult; Middle Aged; Female; Male; Bone Density Conservation Agents; Young Adult; Denosumab
PubMed ID
39673171
PubMed Central ID
PMC12641518
Added to directory
Source checked

Report a correction or request removal